Global Ophthalmology Amniotic Membranes Market Overview
Amniotic membrane is the innermost placental layer with thick basement membrane and an avascular stromal matrix. Human amniotic membranes are derived from inner amniotic fetal membranes which is made up of single layer of amnion cell and attached to chorion. It is a natural and wonderful biological membrane which not only protects the fetus but also can be used in the field of clinical applications such as ophthalmology, dermatology, dental surgery, Ear, Nose, Throat (ENT) surgery, orthopedics, etc. Amniotic membrane is widely used in eye surgery as a graft and dressing to facilitate healing and reconstruction of ocular surface. It is lightweight, elastic, thin and transparent due to which it can be used on the surface of eye.
The global ophthalmology amniotic membranes market is driven by increasing adoption of amniotic membrane for various applications across the globe. The increased R&D investments in the field of ophthalmology amniotic membrane have led to more focused research across the globe. Furthermore, increased regulatory harmonization for accelerated pace of product approvals has made an increase in the target market. Besides these, the membrane transplants are like to increase by increase in the number of techniques for transplantation of amniotic membrane. Also fast approval of the amniotic based products to treat the surgical wounds contributes to the growth of the global ophthalmology amniotic membrane market. The safety, convenience, and effectiveness of amniotic membranes are helping to produce excellent outcomes and treat a variety of ocular surface diseases. Amniotic membranes as an ideal biological dressing in ophthalmology is being used worldwide and in turn driving growth of the target market. However, some factors restraining growth of the global market including lack of skilled and experienced professionals, time to reach market due to lengthy clinical trials, lack of standardized procedure and guidelines on tissue engineering across the globe.
Global ophthalmology amniotic membrane market is segmented on the basis of product type, end user and region. On the basis of product type the target market is segmented into cryopreserved and lyophilized. On the basis of end user, the target market is classified into hospitals, ambulatory surgical centers, specialized clinics, research centers and laboratory. On the basis of region, the market is classified as North America, Europe, Asia-Pacific, South America, Middle East and Africa.
Among the regions, North America is leading the global market for ophthalmologyamniotic membrane with maximum number of shares due to the presence of the large number of key companies in the region. European region is at the second highest revenue as its healthcare system is publicly funded and universal healthcare systems are adopted. The Asia-Pacific region is more likely to expand at the highest in the coming period as most of the countries in this region are economically developing and their income is gradually increasing. Also many multinational companies are investing in this region with a great interest.
Key players operating in the global ophthalmology amniotic membranes market includes Amniox Medical, Inc., FzioMed, Inc., Human Regenerative Technologies, LLC., Amnio Technology, LLC., Applied Biologics LLC., Alliqua BioMedical, Inc., Derma Sciences Inc., MiMedx Group, Inc. and Skye Biologics Inc.
Global Ophthalmology Amniotic Membranes Market Table of Contents
Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product Type
- Market Snippet, By End User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
Ophthalmology Amniotic Membranes Market, By Product Type, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Cryopreserved
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Lyophilized
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Ophthalmology Amniotic Membranes Market, By End User, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Specialized Clinics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Research Centers and Laboratory
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Ophthalmology Amniotic Membranes Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By End User , Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By End User , Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By End User , Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By End User , Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By End User , Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East
Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
Company Profiles
- Amniox Medical, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- FzioMed, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Human Regenerative Technologies, LLC.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Amnio Technology, LLC.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Applied Biologics LLC
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Alliqua BioMedical, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Derma Sciences Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- MiMedx Group, Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Skye Biologics Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
The Last Word
- Future Impact
- About Us
- Contact
FAQs
Global ophthalmology amniotic membrane market is segmented on the basis of product type, end-user, and region
The global ophthalmology amniotic membranes market is driven by the increasing adoption of amniotic membranes for various applications across the globe. The increased R&D investments in the field of ophthalmology amniotic membranes have led to more focused research across the globe.
North America is leading the global market for ophthalmologyamniotic membrane with the maximum number of shares due to the presence of a large number of key companies in the region.
The prominent key operating in the global market have adopted key strategies such as collaborations, mergers, acquisitions, and partnerships to strengthen their market outreach and sustain the stiff competition in the market. For instance, in January 2020, Amniox Medical, Inc., a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced the results from a single-center, prospective, investigator-initiated pilot study titled “Injectable Amniotic Membrane/Umbilical Cord Particulate for Knee Osteoarthritis.”